Storia in 16 fonti

Marty Makary out as FDA chief

His tenure was marked by organizational upheaval, controversies over drug approvals and tensions with the White House.

Raccontata da

cnbc.com+4 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

axios.comStai leggendo3 mesi fa

Marty Makary out as FDA chief

His tenure was marked by organizational upheaval, controversies over drug approvals and tensions with the White House.

originale

biopharmadive.com

Timeline cronologica

lunedì 11 maggio 2026·politico.com
Makary keeps working amid questions over his FDA future
The embattled FDA chief is still scheduled to testify Wednesday on Capitol Hill.
martedì 12 maggio 2026·healio.com
Makary out as FDA commissioner
Martin Makary, MD, MPH, is resigning as FDA commissioner.Politico was first to report the news on Tuesday, citing an administration official who was granted anonymity. The…

3 mesi fa

FDA chief Marty Makary resigns from agency, ending tumultuous tenure

Makary’s exit ends a turbulent run marred by leadership upheaval, mass layoffs, political pressure and public spats with drugmakers.

Leggi questa versione → originale

rollcall.com3 mesi fa

Makary out at FDA after facing pressure to resign

Food and Drug Administration Commissioner Marty Makary will leave his role, President Donald Trump said Tuesday. Makary’s departure comes after pressure within the administration to step down over a variety of issues,…

Leggi questa versione → originale

thedispatch.com3 mesi fa

Marty Makary’s Turbulent Tenure at FDA Comes to an End

Brought in as an agency critic, the commissioner drew fire from drug developers and abortion foes.

Leggi questa versione → originale

bbc.com3 mesi fa

Marty Makary out as head of US Food and Drug Administration

Makary is the latest top health official to be ousted under Health Secretary Robert F Kennedy Jr.

Leggi questa versione → originale

statnews.com3 mesi fa

Makary departs FDA amid turmoil as Diamantas, agency's top food official, steps in

Food and Drug Administration Commissioner Marty Makary is resigning from his role after a tumultuous tenure.

Leggi questa versione → originale

martedì 12 maggio 2026·

forbes.com

FDA Commissioner Marty Makary Resigns

Trump was reportedly considering firing Makary.

martedì 12 maggio 2026·

biopharmadive.com

FDA chief Marty Makary resigns from agency, ending tumultuous tenure

Makary’s exit ends a turbulent run marred by leadership upheaval, mass layoffs, political pressure and public spats with drugmakers.

martedì 12 maggio 2026·

apnews.com

Trump's FDA chief is out after angering pharma CEOs, vaping lobbyists and anti-abortion activists

Marty Makary is resigning as President Donald Trump's Food and Drug Administration chief. The surgeon and health researcher's tenure had drawn complaints from pharmaceutical…

martedì 12 maggio 2026·

endpoints.news

FDA Commissioner Makary resigns

FDA Commissioner Marty Makary is set to resign after his status hung in the balance for days.

martedì 12 maggio 2026·

statnews.com

Makary departs FDA amid turmoil as Diamantas, agency's top food official, steps in

Food and Drug Administration Commissioner Marty Makary is resigning from his role after a tumultuous tenure.

martedì 12 maggio 2026·

ansa.it

Si è dimesso il capo della Food and Drug Administration Usa Makary - Ultima ora - Ansa.it

Marty Makary ha lasciato l'incarico di capo della Food and Drug Administration dopo settimane di speculazioni che Donald Trump avesse intenzione di cacciarlo per le sue posizioni…

martedì 12 maggio 2026·

ansa.it

Si è dimesso il capo della Food and Drug Administration Usa Makary - Notizie - Ansa.it

Marty Makary ha lasciato l'incarico di capo della Food and Drug Administration dopo settimane di speculazioni che Donald Trump avesse intenzione di cacciarlo per le sue posizioni…

martedì 12 maggio 2026·

axios.com

Marty Makary out as FDA chief

His tenure was marked by organizational upheaval, controversies over drug approvals and tensions with the White House.

martedì 12 maggio 2026·

huffpost.com

Trump FDA Chief Is Leaving After Angering Pharma CEOs, Vaping Lobbyists And Anti-Abortion Groups

Marty Makary is resigning after just over a year leading the powerful health regulatory agency.

martedì 12 maggio 2026·

bbc.com

Marty Makary out as head of US Food and Drug Administration

Makary is the latest top health official to be ousted under Health Secretary Robert F Kennedy Jr.

martedì 12 maggio 2026·

politico.com

Makary’s time atop FDA over, Diamantas named acting commissioner

The gastrointestinal surgeon’s tenure was marked by mass layoffs, persistent churn among senior leaders and policy fights.

martedì 12 maggio 2026·

cnbc.com

Trump says Makary is out as FDA commissioner, following industry and White House backlash

Makary's tenure was marked by internal dysfunction at the FDA, leadership turmoil and mounting backlash from drugmakers and physicians on regulatory decisions.

martedì 12 maggio 2026·

usatoday.com

FDA Commissioner Marty Makary resigns after pressure campaign

FDA Commissioner Marty Makary resigned, President Donald Trump said, marking the latest high-profile leadership shakeup at HHS.

martedì 12 maggio 2026·

rollcall.com

Makary out at FDA after facing pressure to resign

Food and Drug Administration Commissioner Marty Makary will leave his role, President Donald Trump said Tuesday. Makary’s departure comes after pressure within the administration…

martedì 12 maggio 2026·

upi.com

FDA Commissioner Martin Makary exits post after 13 months on job - UPI.com

Food and Drug Administration Commissioner Martin Makary has exited the post after 13 sometimes stormy months on the job, the White House said.

martedì 12 maggio 2026·

statnews.com

Why Marty Makary was the worst FDA commissioner in 25 years

Marty Makary, who resigned under pressure from the FDA, brought to the job a fundamental lack of understanding of the nature of the role, STAT's Matthew Herper writes.

mercoledì 13 maggio 2026·

spiegel.de

Chef der US-Gesundheitsbehörde FDA tritt zurück

Der Chef der Arznei- und Lebensmittelbehörde FDA stemmte sich etwa gegen fruchtige E-Zigaretten – und lag auch sonst mit der Trump-Regierung oft im Clinch. Nun hat der…

mercoledì 13 maggio 2026·

biopharmadive.com

FDA’s leadership void leaves biotech with renewed ‘uncertainty’

Marty Makary's resignation leaves the agency with temporary directors in three top positions, and a number of newly instituted policies with an unclear future.

Marty Makary out as FDA chief

Timeline cronologica

Makary keeps working amid questions over his FDA future

Makary out as FDA commissioner

FDA chief Marty Makary resigns from agency, ending tumultuous tenure

Makary out at FDA after facing pressure to resign

Marty Makary’s Turbulent Tenure at FDA Comes to an End

Marty Makary out as head of US Food and Drug Administration

Makary departs FDA amid turmoil as Diamantas, agency's top food official, steps in

FDA Commissioner Marty Makary Resigns

FDA chief Marty Makary resigns from agency, ending tumultuous tenure

Trump's FDA chief is out after angering pharma CEOs, vaping lobbyists and anti-abortion activists

FDA Commissioner Makary resigns

Makary departs FDA amid turmoil as Diamantas, agency's top food official, steps in

Si è dimesso il capo della Food and Drug Administration Usa Makary - Ultima ora - Ansa.it

Si è dimesso il capo della Food and Drug Administration Usa Makary - Notizie - Ansa.it

Marty Makary out as FDA chief

Trump FDA Chief Is Leaving After Angering Pharma CEOs, Vaping Lobbyists And Anti-Abortion Groups

Marty Makary out as head of US Food and Drug Administration

Makary’s time atop FDA over, Diamantas named acting commissioner

Trump says Makary is out as FDA commissioner, following industry and White House backlash

FDA Commissioner Marty Makary resigns after pressure campaign

Makary out at FDA after facing pressure to resign

FDA Commissioner Martin Makary exits post after 13 months on job - UPI.com

Why Marty Makary was the worst FDA commissioner in 25 years

Chef der US-Gesundheitsbehörde FDA tritt zurück

FDA’s leadership void leaves biotech with renewed ‘uncertainty’